Erschienen in:
01.05.2009 | Mini Review
Oncomodulation by human cytomegalovirus: evidence becomes stronger
verfasst von:
Martin Michaelis, Hans Wilhelm Doerr, Jindrich Cinatl Jr
Erschienen in:
Medical Microbiology and Immunology
|
Ausgabe 2/2009
Einloggen, um Zugang zu erhalten
Excerpt
The human cytomegalovirus (HCMV), a ubiquitous herpes virus, establishes after (in healthy individuals typically subclinical) primary infection a lifelong persistence characterised by more or less frequent subclinical reactivations. It is an important pathogen in immunocompromised individuals and currently investigated for a plethora of different questions and aspects [
1‐
25]. The (possible) relationship between HCMV and cancer has been discussed for decades [
1]. Detection of viral DNA, mRNA and/or antigens in tumour tissues as well as seroepidemiologic evidence suggested a role of HCMV infection in several human malignancies. However, controversial clinical results from different groups had raised skepticism about a role of HCMV in cancer [
1]. …